The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 612.00
Bid: 612.00
Ask: 614.00
Change: -2.00 (-0.33%)
Spread: 2.00 (0.327%)
Open: 620.00
High: 620.00
Low: 612.00
Prev. Close: 614.00
PRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

27 Jun 2011 07:00

RNS Number : 1259J
Porvair PLC
27 June 2011
 



For immediate release 27 June 2011

 

Porvair plc

Half yearly results for the six months ended 31 May 2011

 

Porvair plc ("Porvair" or "the Group"), the specialist filtration and environmental technology group, today announces its half yearly results for the six months ended 31 May 2011.

 

Highlights

·; Revenues grew by 5% (7% in constant currency) to £31.1m (2010: £29.7m).

·; Profit before tax increased by 27% to £1.6m (2010: £1.3m).

·; Earnings per share up 29% to 2.7 pence (2010: 2.1 pence).

·; Management's expectations for the full year have been increased.

·; Net debt fell substantially by £5.4m to £8.9m over the last 12 months (2010: £14.3m).

·; Metals Filtration:

o Further take up of patented new products leading to improved margins;

o Streamlining manufacturing processes underway;

o First profitable period for Chinese plant.

·; Microfiltration:

o Aerospace revenues up 17% with promising schedules for the second half;

o Record orders in the second quarter, including several large bids won in gasification and nuclear;

o Seal Analytical revenues lower by 9% compared with prior period but expected to perform well over the full year.

·; Interim dividend of 1.0 pence (2010: 1.0 pence) declared.

 

Commenting on the outlook, Ben Stocks, Chief Executive, said:

"Porvair's strategic direction and operating objectives, which focus on new product growth and geographic expansion in key markets, have been consistent for several years, and their benefits are discernable in these results. The Board expects these benefits to continue to show through in the second half of 2011 and beyond. In the Metals Filtration division margins are improving and will continue to do so as manufacturing is streamlined. In Microfiltration, the strength of the current order book and pipeline of potential opportunities is encouraging. As a result, management's expectations for the year have been increased."

 

 

For further information please contact:

Porvair plc

0207 466 5000

today

Ben Stocks, Chief Executive

01553 765 500

thereafter

Chris Tyler, Group Finance Director

Buchanan Communications

0207 466 5000

Charles Ryland / Catherine Breen

 

A copy of the presentation that accompanies these results is available at www.porvair.com 

Chief Executive's review

Overview

Porvair has continued to make good progress against its objectives for 2011 and this is shown in the performance for the six months ended 31 May 2011:

 

·; Revenues grew by 5% (7% in constant currency) to £31.1m (2010: £29.7m).

·; Profit before tax rose by 27% to £1.6m (2010: £1.3m).

·; Earnings per share increased by 29% to 2.7 pence (2010: 2.1 pence).

·; Net debt reduced by £5.4m to £8.9m over the last 12 months (2010: £14.3m).

 

These improvements have been driven by: investment in new and patented products; steady geographic expansion in key sectors; and stronger demand in certain areas. Sales from new and patented products, key to our plans for organic growth since 2004/5, contributed 30% (2010: 23%; 2009: 13%) of sales revenues in the period. Further investments in people and equipment have been made in the plants in China and the Microfiltration plant in the US. Demand in aluminium, US auto and aerospace markets have been stronger in 2011.

 

The Group's order book has strengthened steadily over the first half of the year. The outlook for the second half is promising and management's expectations for the full year have been increased as a result.

 

Porvair's activities and strategy

Porvair specialises in filtration and related environmental technology. We operate two divisions. The Microfiltration division comprises the Porvair Filtration Group, Porvair Sciences and Seal Analytical ('Seal'). It principally serves aviation, environmental laboratory and energy markets. The Metals Filtration division serves global aluminium, NAFTA iron foundry and super-alloy markets.

The Group manufactures in the UK, US, Germany and China. Its sales are global.

Porvair's strategy for growth and the creation of sustainable shareholder value is to:

·; Develop filtration and environmental technology positions in markets where typically:

o specialist design or engineering skills win business;

o regulation or quality accreditation requirements mandate product use;

o consumable products, which protect more costly downstream components, are often replaced as part of a maintenance routine;

o products, once designed into a specification, have very long lifecycles.

·; Focus on selected markets which have good long term growth: aviation, energy & industrial, environmental laboratory supplies and aluminium filtration.

·; Invest consistently in specified new products.

·; Expand geographically, where appropriate, in our chosen markets.

·; Acquire complementary businesses that meet Group financial and commercial criteria.

·; Maintain an appropriately funded balance sheet and generate sufficient cash to sustain a

progressive dividend policy.

 

Operating review

 

Metals Filtration

Revenues increased 8% (12% in constant currency) to £12.2m (2010: £11.3m). Operational gearing and improved margins from new and patented products substantially improved operating profits and it is a pleasure to be able to report a doubling of revenue and a maiden profit at the division's satellite plant in Wuhan, China.

 

Customers' markets have been stronger in the period: aluminium production has increased buoyed by a stronger aluminium price; US car production has increased throughout the period; and improved airline passenger numbers have increased aircraft usage.

 

Revenue and margin growth is further supported by the adoption of three patented products introduced in recent years: Selee CSX for aluminium filtration; Selee SA for NiCo alloy filtration; and Selee IC for the filtration of gray and ductile iron. The first two products have now been fully adopted by our existing customers and the aluminium CSX filter has started to make market share gains. The last to be developed, Selee IC, has now been adopted by around half our customers, and this proportion is expected to increase in the second half of the year. These new products contribute better margins to the business and allow manufacturing to be streamlined. As a result, one of the three main production lines in our US facility was shut down towards the end of the period, with capacity being taken up in other lines in the US and China. This will further improve margins in the second half of the year and beyond.

 

Microfiltration

Revenue from Microfiltration grew by 3% to £19.0m (2010: £18.4m). Aerospace revenue grew by 17%, schedules strengthened steadily throughout the period and the growth from inerting filters is ahead of our expectations. Microfiltration took record orders in the second quarter, with several large bids won in the gasification and nuclear markets. The US subsidiary, PFG Inc, continues to trade well and hire staff as it grows.

 

New products continue to be a focus at Porvair and the first half of 2011 saw progress with some bioscience filtration developments on which we have been working for many years. In April we launched Chromatrap™, a product that improves chromatin immunoprecipitation in epigenetic research. This product filters at a molecular level. We expect sales to grow steadily, and can see an interesting path ahead in further developing the technology.

 

Revenues at Seal Analytical were 9% lower (7% in constant currency) compared with a strong first half in 2010. Profitability was in line with expectations but lower than 2010, which benefited from the favourable impact of currency movements. The pipeline of order prospects is, however, encouraging and we expect Seal to perform well over the full year. A new continuous flow analyser, the Seal AA1, was launched in March, following the new discrete analyser (Seal AQ1) launched in 2010. Both have been well received.

 

Earnings per share and dividends

The basic and diluted earnings per share for the period increased 29% to 2.7 pence (2010: 2.1 pence). The Board is again declaring an interim dividend of 1.0 pence (2010: 1.0 pence) per share. In recent years the interim dividend has remained unchanged, with dividend increments declared at the time of the full year results in January in line with the Group's progressive dividend policy.

 

Cash flow and net debt

Cash generated from operations in the six months to 31 May 2011 was £1.8m (2010: £1.9m). Stronger trading in Microfiltration and a build up of inventory in Metals Filtration prior to the transfer of some production to China has temporarily increased inventories by £1.5m (2010: £0.7m). It is expected that much of this increase in inventories will reverse over the next nine months. £1.3m (€1.6m) was collected in the period from the maturity of a long term interest bearing receivable, underlying receivables increased as a result of strong trading in the second quarter.

 

Net interest paid was £0.3m (2010: £0.3m), tax paid was £0.7m (2010: £0.3m) and capital expenditure was £0.8m (2010: £0.6m).

 

Proceeds of £0.3m (2010: £nil) were received on the exercise of share options and exchange rate movements reduced net debt by £0.5m (2010: increased £1.0m). Closing net debt at 31 May 2011 was £8.9m (31 May 2010: £14.3m; 30 November 2010: £9.7m).

 

Current trading and outlook

Porvair's strategic direction and operating objectives, which focus on new product growth and geographic expansion in key markets, have been consistent for several years, and their benefits are discernable in these results. The Board expects these benefits to continue to show through in the second half of 2011 and beyond. In the Metals Filtration division margins are improving and will continue to do so as manufacturing is streamlined. In Microfiltration, the strength of the current order book and pipeline of potential opportunities is encouraging. As a result, management's expectations for the year have been increased.

 

 

 

 

 

Ben Stocks

Group Chief Executive

 

 

 

 

 

Related parties

There were no related party transactions in the six months ended 31 May 2011.

 

Principal risks

Each division considers strategic, operational and financial risks and identifies actions to mitigate those risks. These risk profiles are reviewed by the Board and updated at least annually. The principal risks and uncertainties for the remaining six months of the financial year are discussed below. Further details of the Group's risk profile analysis can be found in the Annual Report for the year ended 30 November 2010.

 

As was shown in 2009, certain elements of the Group's order position, although healthy at 31 May 2011, can change quickly in the face of changing economic circumstances. The Metals Filtration division and environmental laboratory supplies and general industrial filtration within the Microfiltration division all have relatively short lead times and order cycles. The orders are, therefore, subject to fluctuations that could have a material effect on the Group's results for the balance of 2011.

 

The Microfiltration division serves several customers whose orders are quite large relative to Porvair's overall order book. Should any of these be cancelled or delayed it may affect the Group's results for the balance of 2011.

 

Forward looking statements

Certain statements in this half yearly financial report are forward-looking. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. Because these statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements.

 

We undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

 

Consolidated income statement

For the six months ended 31 May

Six months ended 31 May

2011

2010

Note

Unaudited

Unaudited

£'000

£'000

Revenue

1

31,131

29,661

Cost of sales

(20,590)

(19,917)

Gross profit

10,541

9,744

Other operating expenses

(8,516)

(8,021)

Operating profit

1

2,025

1,723

Interest payable and similar charges

(409)

(577)

Interest receivable

12

134

Profit before income tax

1,628

1,280

Income tax expense

(494)

(412)

Profit for the period attributable to shareholders

1,134

868

Earnings per share (basic)

2

2.7p

2.1p

Earnings per share (diluted)

2

2.7p

2.1p

 

 

 

 

Consolidated statement of comprehensive income

For the six months ended 31 May

Six months ended 31 May

2011

Unaudited

2010

Unaudited

£'000

£'000

Profit for the period

1,134

868

Other comprehensive (expense)/income:

Exchange differences on translation of foreign subsidiaries

(712)

1,970

Changes in fair value of interest rate swaps held as a cash flow hedge

52

31

Net other comprehensive (expense)/income

(660)

2,001

Total comprehensive income for the period attributable to shareholders of Porvair plc

 

474

 

2,869

 

The accompanying notes are an integral part of this interim financial information.

 

 

Consolidated balance sheet

As at 31 May

 

As at 31 May

As at 30 November

Note

2011

Unaudited

2010

Unaudited

2010

Audited

£'000

£'000

£'000

Non-current assets

Property, plant and equipment

4

8,486

9,255

8,659

Goodwill and other intangible assets

4

36,496

39,500

37,916

Deferred tax asset

1,794

2,768

1,652

46,776

51,523

48,227

Current assets

Inventories

9,164

9,277

7,727

Trade and other receivables

10,653

11,820

11,330

Derivative financial instruments

136

-

-

Cash and cash equivalents

4,248

2,795

5,897

24,201

23,892

24,954

Current liabilities

Trade and other payables

(10,563)

(9,496)

(10,402)

Current tax liabilities

(542)

(845)

(777)

Bank overdraft and loans

(921)

(1,964)

(2,344)

Finance lease liabilities

(18)

(92)

(34)

Derivative financial instruments

(218)

(555)

(284)

(12,262)

(12,952)

(13,841)

Net current assets

11,939

10,940

11,113

Non-current liabilities

Bank loans

(12,201)

(14,999)

(13,188)

Finance lease liabilities

-

(18)

(6)

Retirement benefit obligations

(5,414)

(8,552)

(5,594)

Provisions for other liabilities and charges

(74)

(68)

(71)

(17,689)

(23,637)

(18,859)

Net assets

41,026

38,826

40,481

Capital and reserves

Share capital

5

848

841

841

Share premium account

5

34,366

34,024

34,024

Cumulative translation reserve

6

90

2,393

802

Retained earnings

6

5,722

1,568

4,814

Total equity

41,026

38,826

40,481

 

The interim financial statements on pages 5 to 14 were approved by the Board of Directors on 24 June 2011 and were signed on its behalf by:

 

Ben Stocks Christopher Tyler

Group Chief Executive Group Finance Director

 

The accompanying notes are an integral part of this interim financial information.

Consolidated cash flow statement

For the six months ended 31 May

Six months ended 31 May

Note

2011

Unaudited

2010

Unaudited

£'000

£'000

Cash flows from operating activities

Cash generated from operations

7

1,776

1,908

Interest received

85

155

Interest paid

(416)

(485)

Tax paid

(694)

(333)

Net cash generated from operating activities

751

1,245

Cash flows from investing activities

Purchase of property, plant and equipment

4

(799)

(567)

Purchase of intangible assets

4

(15)

(39)

Proceeds from sale of property, plant and equipment

19

-

Net cash (used in) investing activities

(795)

(606)

Cash flows from financing activities

Net proceeds from the issue of ordinary shares

5

349

-

(Repayment) of borrowings

8

(1,892)

(1,284)

Capital element of finance leases

8

(22)

(72)

Net cash (used in) financing activities

(1,565)

(1,356)

Net (decrease) in cash and cash equivalents

8

(1,609)

(717)

Effects of exchange rate changes

(40)

128

(1,649)

(589)

Cash and cash equivalents at the beginning of the period

5,897

3,384

Cash and cash equivalents at the end of the period

4,248

2,795

 

 

The accompanying notes are an integral part of this interim financial information.

Consolidated statement of changes in equity

For the six months ended 31 May (Unaudited)

 

 

 

Share capital

£'000

Share premium account

£'000

Cumulative translation

reserve

£'000

 

Retained earnings

£'000

 

 

Total

£'000

Balance at 1 December 2009

841

34,024

423

1,107

36,395

Profit for the period

-

-

-

868

868

Other comprehensive income for the period:

Exchange differences on translation of foreign subsidiaries

 

-

 

-

 

1,970

 

-

 

1,970

Changes in fair value of interest rate swaps held as a cash flow hedge

 

-

 

-

 

-

 

31

 

31

Total comprehensive income for the period

 

-

 

-

 

1,970

 

899

 

2,869

Transactions with owners:

Employee share option schemes:

Value of employee services net of tax

-

-

-

88

88

Dividends approved or paid

-

-

-

(526)

(526)

Balance at 31 May 2010

841

34,024

2,393

1,568

38,826

Balance at 1 December 2010

841

34,024

802

4,814

40,481

Profit for the period

-

-

-

1,134

1,134

Other comprehensive (expense) / income for the period:

Exchange differences on translation of foreign subsidiaries

 

-

 

-

 

(712)

 

-

 

(712)

Changes in fair value of interest rate swaps held as a cash flow hedge

 

-

 

-

 

-

 

52

 

52

Total comprehensive (expense) / income for the period

 

-

 

-

 

(712)

 

1,186

 

474

Transactions with owners:

Proceeds from shares issued, net of costs

 

7

 

342

 

-

 

-

 

349

Employee share option schemes:

Value of employee services net of tax

-

-

-

274

274

Dividends approved or paid

-

-

-

(552)

(552)

Balance at 31 May 2011

848

34,366

90

5,722

41,026

 

 

The accompanying notes are an integral part of this interim financial information.

 

Notes to the accounts

 

1. Segmental analyses

 

The chief operating decision maker has been identified as the Board of Directors. The Board of Directors review the Group's internal reporting in order to assess performance and allocate resources. Management have determined the operating segments based on this reporting.

 

As at 31 May 2011, the Group is organised on a worldwide basis into two operating segments:

1) Metals Filtration

2) Microfiltration

 

The segment results for the period ended 31 May 2011 are as follows:

 

Six months ended 31 May 2011 - Unaudited

Metals Filtration

Microfiltration

Other unallocated

Group

£'000

£'000

£'000

£'000

Revenue

12,172

18,959

-

31,131

Operating profit/(loss)

540

2,189

(704)

2,025

Finance costs

-

-

(397)

(397)

Profit/(loss) before income tax

540

2,189

(1,101)

1,628

Income tax expense

-

-

(494)

(494)

Profit/(loss) for the period

540

2,189

(1,595)

1,134

 

The segment results for the period ended 31 May 2010 are as follows:

 

Six months ended 31 May 2010 - Unaudited

Metals Filtration

Microfiltration

Other unallocated

Group

£'000

£'000

£'000

£'000

Revenue

11,307

18,354

-

29,661

Operating profit/(loss)

276

2,080

(633)

1,723

Finance costs

-

-

(443)

(443)

Profit/(loss) before income tax

276

2,080

(1,076)

1,280

Income tax expense

-

-

(412)

(412)

Profit/(loss) for the period

276

2,080

(1,488)

868

 

The Other unallocated segment mainly comprises Group corporate costs not directly allocated, some research and development costs not directly allocated, new business development costs, tax, and general finance costs.

Segment assets and liabilities

 

At 31 May 2011 - Unaudited

Metals Filtration

Microfiltration

Other unallocated

Group

£'000

£'000

£'000

£'000

Segmental assets

25,420

39,126

2,183

66,729

Cash and cash equivalents

-

-

4,248

4,248

Total assets

25,420

39,126

6,431

70,977

Segmental liabilities

(2,797)

(6,718)

(1,882)

(11,397)

Retirement obligations

-

-

(5,414)

(5,414)

Borrowings

-

(18)

(13,122)

(13,140)

Total liabilities

(2,797)

(6,736)

(20,418)

(29,951)

 

At 31 May 2010 - Unaudited

Metals Filtration

Microfiltration

Other unallocated

Group

£'000

£'000

£'000

£'000

Segmental assets

29,424

39,101

4,095

72,620

Cash and cash equivalents

-

-

2,795

2,795

Total assets

29,424

39,101

6,890

75,415

Segmental liabilities

(3,015)

(6,017)

(1,932)

(10,964)

Retirement obligations

-

-

(8,552)

(8,552)

Borrowings

-

(110)

(16,963)

(17,073)

Total liabilities

(3,015)

(6,127)

(27,447)

(36,589)

 

At 30 November 2010 - Audited

Metals Filtration

Microfiltration

Other Unallocated

Group

£'000

£'000

£'000

£'000

Segmental assets

25,873

38,061

3,350

67,284

Cash and cash equivalents

-

-

5,897

5,897

Total assets

25,873

38,061

9,247

73,181

Segmental liabilities

(2,767)

(6,805)

(1,962)

(11,534)

Retirement obligations

-

-

(5,594)

(5,594)

Borrowings

-

(40)

(15,532)

(15,572)

Total liabilities

(2,767)

(6,845)

(23,088)

(32,700)

 

Segment assets consist primarily of property, plant and equipment, intangible assets, inventories and receivables.

 

Segment liabilities comprise operating liabilities and include items such as taxation.

Geographical analysis

Revenue

Six months ended 31 May

2011

Unaudited

2010

Unaudited

By destination

£'000

By origin

£'000

By destination

£'000

By origin

£'000

United Kingdom

7,062

13,752

5,693

13,372

Continental Europe

5,158

2,960

4,252

3,419

United States of America

11,583

13,653

12,044

12,851

Other NAFTA

2,038

-

2,267

-

South America

567

-

730

-

Asia

4,122

766

3,989

19

Australasia

114

-

285

-

Africa

487

-

401

-

31,131

31,131

29,661

29,661

 

 

2. Earnings per share

Six months ended 31 May

2011

Unaudited

2010

Unaudited

Earnings

 

 

 

£'000

Weighted average number of shares

Per share amount

 

 

Pence

Earnings

 

 

 

£'000

Weighted average number of shares

Per share amount

 

 

Pence

Basic EPS - Earnings attributable to ordinary shareholders

 

 

1,134

 

 

42,187,437

 

 

2.7

 

 

868

 

 

42,073,640

 

 

2.1

Effect of dilutive securities - share options

 

-

 

81,897

 

-

 

-

 

656

 

-

Diluted EPS

1,134

42,269,334

2.7

868

42,074,296

2.1

 

 

3. Dividends per share

Six months ended 31 May

2011

2010

 

Per share

Unaudited

£'000

 

Per share

Unaudited

£'000

Final dividend approved

1.30p

552

1.25p

526

 

The final dividend approved was paid to shareholders on 10 June 2011.

 

The Directors have declared an interim dividend of 1.0 pence (2010: 1.0 pence) per share to be paid on 9 September 2011 to shareholders on the register at the close of business on 5 August 2011. The ex-dividend date for the shares is 3 August 2011.

 

4. Property, plant and equipment and goodwill and other intangible assets

 

Six months ended 31 May 2011 - Unaudited

Property, plant and equipment

Goodwill and other intangible assets

Total

£'000

£'000

£'000

Opening net book amount at 1 December 2010

8,659

37,916

46,575

Additions

799

15

814

Disposals

(3)

-

(3)

Depreciation, amortisation, impairment and other movements

 

(969)

 

(1,435)

 

(2,404)

Closing net book amount at 31 May 2011

8,486

36,496

44,982

 

 

Six months ended 31 May 2010 - Unaudited

Property, plant and equipment

Goodwill and other intangible assets

Total

£'000

£'000

£'000

Opening net book amount at 1 December 2009

8,872

37,634

46,506

Additions

567

39

606

Disposals

(1)

-

(1)

Depreciation, amortisation, impairment and other movements

 

(183)

 

1,827

 

1,644

Closing net book amount at 31 May 2010

9,255

39,500

48,755

 

 

5. Share capital and premium

Number of shares (thousands)

Ordinary shares

Unaudited

Share premium account

Unaudited

 

Total

Unaudited

£'000

£'000

£'000

At 1 Dec 2009, 31 May 2010 and 1 Dec 2010

 

42,074

 

841

 

34,024

 

34,865

Employee share options schemes:

Proceeds from the exercise of options under share option schemes

 

352

 

7

 

342

 

349

At 31 May 2011

42,426

848

34,366

35,214

 

The authorised number of ordinary shares is 75 million (2010: 75 million) shares with a par value of 2.0 pence (2010: 2.0 pence) per share. All issued shares are fully paid.

 

In January 2011, 352,000 ordinary shares of 2.0 pence each were issued on the exercise of employee share options for cash consideration of £349,000.

6. Other reserves

Cumulative translation reserve

Unaudited

 

Retained earnings

Unaudited

£'000

£'000

At 1 December 2009

423

1,107

Profit for the period attributable to shareholders

-

868

Direct to equity:

Dividends approved

-

(526)

Share based payments

-

66

Tax on share based payments

-

22

Interest rate swap cash flow hedge

-

31

Exchange differences

1,970

-

At 31 May 2010

2,393

1,568

At 1 December 2010

802

4,814

Profit for the period attributable to shareholders

-

1,134

Direct to equity:

Dividends approved

-

(552)

Share based payments

-

103

Tax on share based payments

-

171

Interest rate swap cash flow hedge

-

52

Exchange differences

(712)

-

At 31 May 2011

90

5,722

 

7. Cash generated from operations

Six months ended 31 May

2011

Unaudited

£'000

2010

Unaudited

£'000

Operating profit

2,025

1,723

Non-cash pension charge

200

300

Share based payments

103

66

Depreciation, amortisation and impairment

1,370

1,017

Profit on disposal of property, plant and equipment

(16)

(1)

Operating cash flows before movement in working capital

3,682

3,105

(Increase) in inventories

(1,545)

(663)

Decrease/(increase) in trade and other receivables

301

(1,150)

(Decrease)/increase in payables

(662)

616

(Increase) in working capital

(1,906)

(1,197)

Cash generated from operations

1,776

1,908

 

8. Reconciliation of net cash flow to movement in net debt

Six months ended 31 May

2011

Unaudited

£'000

2010

Unaudited

£'000

Net (decrease) in cash and cash equivalents

(1,609)

(717)

Effects of exchange rate changes

478

(1,007)

Repayment of borrowings

1,892

1,284

Repayment of finance leases

22

72

Net debt at the beginning of the period

(9,675)

(13,910)

Net debt at the end of the period

(8,892)

(14,278)

 

 

9. Exchange rates

Exchange rates for the US dollar during the period were:

Average rate to 31 May 11

Average rate to 31 May 10

Closing rate at 31 May 11

Closing rate at 30 Nov 10

Unaudited

Unaudited

Unaudited

Audited

US dollar

1.61

1.55

1.65

1.56

 

 

10. Seasonality

The results for the six months ended 31 May 2011 are impacted by a lower number of working days in the first six months of the year than in the second half of the year. The number of working days is 7% lower in the first six months of the year compared to the second half of the year.

 

11. Basis of preparation

Porvair plc is a public limited company registered in the UK and listed on the London Stock Exchange.

 

This unaudited condensed half-yearly consolidated financial information for the six months ended 31 May 2011 has been prepared in accordance with the Disclosure and Transparency Rules ('DTR') of the Financial Services Authority and with IAS 34, 'Interim financial reporting' as adopted by the European Union. The condensed half-yearly consolidated financial information should be read in conjunction with the annual financial statements for the year ended 30 November 2010, which have been prepared in accordance with IFRSs as adopted by the European Union.

 

The accounting policies adopted are consistent with those of the annual financial statements for the year ended 30 November 2010, as described in those financial statements. As at the date of signing the interim financial statements, there are no new standards likely to affect the financial statements for the year ending 30 November 2011.

 

Taxes on income in the interim period are accrued using the tax rate that would be applicable to expected total annual earnings.

 

This condensed half-yearly consolidated financial information has been prepared on a going concern basis under the historical cost convention, as modified by the revaluation of certain current assets, financial assets and financial liabilities held for trading and derivative contracts, which are held at fair value.

 

The preparation of condensed half-yearly consolidated financial information in conformity with generally accepted accounting principles requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed half-yearly consolidated financial information and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management's best knowledge of the amount, event or actions, actual results may ultimately differ from those estimates.

 

This condensed half-yearly consolidated financial information and the comparative figures does not constitute full accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 30 November 2010, which include an unqualified audit report, no emphasis of matter paragraph and no statements under sections 498(2) or (3) of the Companies Act 2006, have been delivered to the Registrar of Companies.

 

This report will be available at Porvair plc's registered office at 7 Regis Place, Bergen Way, King's Lynn, PE30 2JN and on the Company's website www.porvair.com.

 

 

Statement of directors' responsibilities

 

The directors confirm that, to the best of their knowledge, this condensed half-yearly consolidated financial information has been prepared in accordance with IAS 34 as adopted by the European Union and that the interim management report herein includes a fair review of the information required by DTR 4.2.7R and DTR 4.2.8R, namely:

§ an indication of important events that have occurred during the first six months of the year, their impact on the condensed half-yearly consolidated financial information and a description of the principal risks and uncertainties for the remaining six months of the financial year; and

§ material related party transactions in the first six months of the year and any material changes in the related party transactions described in the last annual report.

 

The directors of Porvair plc are listed in the Porvair plc Annual Report for the year ended 30 November 2010. There have been no changes in directors in the period. A list of current directors is maintained on the Porvair plc website www.porvair.com.

 

By order of the board

 

 

 

 

Ben Stocks

Group Chief Executive

 

 

 

 

Christopher Tyler

Group Finance Director

 

24 June 2011

 

 

Independent review report to Porvair plc

 

Introduction

We have been engaged by the company to review the condensed half-yearly consolidated financial information in the half-yearly financial report for the six months ended 31 May 2011, which comprises the consolidated income statement, the consolidated statement of comprehensive income, the consolidated balance sheet as at 31 May 2011, the consolidated cash flow statement, the consolidated statement of changes in equity and related notes. We have read the other information contained in the half-yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed half-yearly consolidated financial information.

 

Directors' responsibilities

The half-yearly financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority.

 

As disclosed in note 11, the annual financial statements of the group are prepared in accordance with IFRSs as adopted by the European Union. The condensed half-yearly consolidated financial information included in this half-yearly financial report has been prepared in accordance with International Accounting Standard 34, "Interim Financial Reporting", as adopted by the European Union.

 

Our responsibility

Our responsibility is to express to the company a conclusion on the condensed half-yearly consolidated financial information in the half-yearly financial report based on our review. This report, including the conclusion, has been prepared for and only for the company for the purpose of the Disclosure and Transparency Rules of the Financial Services Authority and for no other purpose. We do not, in producing this report, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.

 

Scope of review

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

 

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the condensed half-yearly consolidated financial information in the half-yearly financial report for the six months ended 31 May 2011 is not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority.

 

 

 

PricewaterhouseCoopers LLPChartered Accountants24 June 2011Cambridge

 

Notes:

 

(a) The maintenance and integrity of the Porvair plc website is the responsibility of the directors; the work carried out by the auditors does not involve consideration of these matters and, accordingly, the auditors accept no responsibility for any changes that may have occurred to the condensed half-yearly consolidated financial information since it was initially presented on the website.

 

(b) Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR DBGDLBDDBGBL
Date   Source Headline
23rd Apr 20241:38 pmRNSDirector/PDMR Shareholding
16th Apr 20242:56 pmRNSAGM Results Announcement
16th Apr 20247:00 amRNSAGM Trading Update & Board Update
3rd Apr 20247:00 amRNSDirector resignation
12th Mar 20247:00 amRNSDirector declaration
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20244:41 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSResults for the year ended 30 November 2023
1st Feb 20247:00 amRNSBlock listing Interim Review
19th Dec 202310:25 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSTrading Update & Acquisition
4th Dec 202312:00 pmRNSHolding(s) in Company
25th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSNine Month Trading Update
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSAcquisition completion
7th Jul 20234:00 pmRNSBlock Listing Application
3rd Jul 20237:00 amRNSInterim Results
26th Jun 20237:00 amRNSBoard Change
21st Jun 20234:22 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSBlock listing Interim Review
4th May 20237:00 amRNSAcquisitions
18th Apr 202312:51 pmRNSAGM resolutions
18th Apr 20237:00 amRNSAGM Trading Update
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.